Article
Interleukin-7 promotes HIV persistence during antiretroviral therapy.
Blood - 23 May 2013
Vandergeeten Claire, Fromentin Rémi, DaFonseca Sandrina, Lawani Mariam B, Sereti Irini, Lederman Michael M, Ramgopal Moti, Routy Jean-Pierre, Sékaly Rafick-Pierre, Chomont Nicolas
Abstract excerpt
HIV persists in latently infected memory CD4(+) T cells during antiretroviral therapy (ART). When administered to HIV-infected subjects receiving suppressive ART, interleukin-7 (IL-7) increases the number of CD4(+) T cells by promoting their survival and proliferation. However, little is known about the impact of IL-7 on HIV persistence during ART. By isolating large numbers of CD4(+) T cells from HIV-infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
